Evidence map›Paper›PMID 38835510›Full record

ArticleFrontiers in cell and developmental biology2024

Gene-deficient mouse model established by CRISPR/Cas9 system reveals 15 reproductive organ-enriched genes dispensable for male fertility.

Tuyen Thi Thanh Nguyen, Keizo Tokuhiro, Keisuke Shimada, Haoting Wang, Daisuke Mashiko, Shingo Tonai, Daiji Kiyozumi, Masahito Ikawa

Abstract read
In one paragraph

Article in Frontiers in cell and developmental biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Tuyen Thi Thanh Nguyen *Department of Genome Editing, Institute of Biomedical Science, Kansai Medical University, Osaka, Japan.
Keizo Tokuhiro *Department of Genome Editing, Institute of Biomedical Science, Kansai Medical University, Osaka, Japan.
Keisuke ShimadaResearch Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Haoting WangResearch Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Daisuke MashikoResearch Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Shingo TonaiResearch Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Daiji KiyozumiPrecursory Research for Embryonic Science and Technology (PRESTO), Japan Science and Technology Agency, Tokyo, Japan.
Masahito IkawaResearch Institute for Microbial Diseases, Osaka University, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the advent of gene-targeting technology in embryonic stem cells, mice have become a primary model organism for investigating human gene function due to the striking genomic similarities between the two species. With the introduction of the CRISPR/Cas9 system for genome editing in mice, the pace of loss-of-function analysis has accelerated significantly. This has led to the identification of numerous genes that play crucial roles in male reproductive processes, including meiosis, chromatin condensation, flagellum formation in the testis, sperm maturation in the epididymis, and fertilization in the oviduct. Despite the advancements, the functions of many genes, particularly those enriched in male reproductive tissues, remain largely unknown. In our study, we focused on 15 genes and generated 13 gene-deficient mice [

Indexed as

CRISPR/Cas9knockout micemale infertilityspermatozoatestis

Identifiers

PMID38835510
PMCPMC11148293

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.